Xtant Historical Balance Sheet

XTNT Stock

USD 0.56 0.01 1.75%

Trend analysis of Xtant Medical Holdings balance sheet accounts such as Total Assets of 60 M, Other Current Liab of 12.6 M, Total Current Liabilities of 16 M or Total Stockholder Equity of 62 M provides information on Xtant Medical's total assets, liabilities, and equity, which is the actual value of Xtant Medical Holdings to its prevalent stockholders. By breaking down trends over time using Xtant Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Xtant Medical Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Xtant Medical Holdings is a good buy for the upcoming year.

Xtant Medical Inventory

44.54 Million

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xtant Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Xtant Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Xtant Medical Holdings at a specified time, usually calculated after every quarter, six months, or one year. Xtant Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Xtant Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Xtant currently owns. An asset can also be divided into two categories, current and non-current.

Xtant Medical Balance Sheet Chart

At this time, Xtant Medical's Total Current Assets are comparatively stable compared to the past year. Short and Long Term Debt Total is likely to gain to about 50.1 M in 2025, whereas Net Debt is likely to drop slightly above 19.5 M in 2025.

Total Assets Other Current Liab Total Current Liabilities Accounts Payable

Add Fundamental

Total Assets

Total assets refers to the total amount of Xtant Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Xtant Medical Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Xtant Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Xtant Medical Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Xtant Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Xtant Medical Holdings are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from Xtant Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Xtant Medical Holdings current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xtant Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	5.0M	10.4M	12.0M	12.6M
Total Assets	60.2M	92.6M	106.5M	60.0M

Other Current Liab Total Assets

Xtant Medical balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Non Current Assets Total	Non Currrent Assets Other	Common Stock Total Equity	Non Current Liabilities Total	Property Plant And Equipment Gross	Short Term Debt	Intangible Assets
Total Assets		0.09	0.84	0.11	0.7	-0.21	0.92	0.1	0.1	0.73	0.2	0.63	0.32	0.23	0.77	0.65	0.73	0.96	0.81	0.91	0.11	-0.27	0.68	0.5	0.17	0.89
Other Current Liab	0.09		0.29	0.85	-0.48	-0.45	0.04	0.14	0.14	0.63	0.87	0.73	0.64	0.74	-0.37	0.69	-0.41	0.11	-0.05	-0.17	-0.4	-0.17	-0.53	0.78	0.31	-0.11
Total Current Liabilities	0.84	0.29		0.17	0.54	-0.39	0.79	-0.03	-0.03	0.7	0.28	0.7	0.49	0.4	0.59	0.65	0.54	0.85	0.76	0.7	-0.1	-0.28	0.46	0.51	0.55	0.65
Total Stockholder Equity	0.11	0.85	0.17		-0.6	-0.29	-0.04	0.34	0.34	0.48	0.81	0.56	0.44	0.63	-0.49	0.59	-0.52	0.12	-0.19	-0.1	-0.26	-0.11	-0.62	0.64	0.38	0.02
Net Debt	0.7	-0.48	0.54	-0.6		0.05	0.75	-0.27	-0.27	0.31	-0.38	0.17	-0.04	-0.23	0.98	0.14	0.99	0.68	0.77	0.82	0.22	-0.17	0.99	0.03	-0.11	0.72
Retained Earnings	-0.21	-0.45	-0.39	-0.29	0.05		-0.11	-0.57	-0.57	-0.47	-0.68	-0.6	-0.73	-0.9	-0.03	-0.67	-0.03	-0.26	-0.34	0.12	0.63	0.66	0.06	-0.42	-0.39	0.16
Accounts Payable	0.92	0.04	0.79	-0.04	0.75	-0.11		-0.06	-0.06	0.7	0.1	0.59	0.25	0.12	0.81	0.58	0.76	0.9	0.75	0.86	0.18	-0.18	0.74	0.49	0.0	0.81
Cash	0.1	0.14	-0.03	0.34	-0.27	-0.57	-0.06		1.0	0.09	0.47	0.13	0.36	0.53	-0.16	0.37	-0.16	0.05	0.11	-0.14	-0.25	-0.33	-0.17	0.02	0.05	-0.14
Cash And Short Term Investments	0.1	0.14	-0.03	0.34	-0.27	-0.57	-0.06	1.0		0.09	0.47	0.13	0.36	0.53	-0.16	0.37	-0.16	0.05	0.11	-0.14	-0.25	-0.33	-0.17	0.02	0.05	-0.14
Net Receivables	0.73	0.63	0.7	0.48	0.31	-0.47	0.7	0.09	0.09		0.69	0.96	0.58	0.65	0.43	0.94	0.39	0.77	0.53	0.53	-0.25	-0.34	0.27	0.92	0.19	0.54
Common Stock Shares Outstanding	0.2	0.87	0.28	0.81	-0.38	-0.68	0.1	0.47	0.47	0.69		0.79	0.73	0.91	-0.25	0.83	-0.27	0.24	0.1	-0.11	-0.57	-0.45	-0.39	0.82	0.28	-0.08
Inventory	0.63	0.73	0.7	0.56	0.17	-0.6	0.59	0.13	0.13	0.96	0.79		0.72	0.79	0.3	0.96	0.25	0.67	0.49	0.38	-0.33	-0.41	0.12	0.93	0.31	0.38
Other Current Assets	0.32	0.64	0.49	0.44	-0.04	-0.73	0.25	0.36	0.36	0.58	0.73	0.72		0.79	0.08	0.73	0.04	0.25	0.52	0.07	-0.39	-0.54	-0.05	0.6	0.24	-0.01
Other Stockholder Equity	0.23	0.74	0.4	0.63	-0.23	-0.9	0.12	0.53	0.53	0.65	0.91	0.79	0.79		-0.11	0.84	-0.13	0.28	0.23	-0.1	-0.61	-0.58	-0.26	0.69	0.42	-0.1
Total Liab	0.77	-0.37	0.59	-0.49	0.98	-0.03	0.81	-0.16	-0.16	0.43	-0.25	0.3	0.08	-0.11		0.29	0.99	0.74	0.83	0.85	0.21	-0.2	0.98	0.15	-0.12	0.75
Total Current Assets	0.65	0.69	0.65	0.59	0.14	-0.67	0.58	0.37	0.37	0.94	0.83	0.96	0.73	0.84	0.29		0.25	0.68	0.51	0.38	-0.35	-0.45	0.12	0.89	0.26	0.37
Short Long Term Debt Total	0.73	-0.41	0.54	-0.52	0.99	-0.03	0.76	-0.16	-0.16	0.39	-0.27	0.25	0.04	-0.13	0.99	0.25		0.71	0.8	0.83	0.16	-0.24	0.98	0.11	-0.11	0.73
Property Plant And Equipment Net	0.96	0.11	0.85	0.12	0.68	-0.26	0.9	0.05	0.05	0.77	0.24	0.67	0.25	0.28	0.74	0.68	0.71		0.73	0.86	0.0	-0.29	0.65	0.56	0.27	0.85
Current Deferred Revenue	0.81	-0.05	0.76	-0.19	0.77	-0.34	0.75	0.11	0.11	0.53	0.1	0.49	0.52	0.23	0.83	0.51	0.8	0.73		0.76	-0.04	-0.35	0.76	0.28	0.11	0.62
Non Current Assets Total	0.91	-0.17	0.7	-0.1	0.82	0.12	0.86	-0.14	-0.14	0.53	-0.11	0.38	0.07	-0.1	0.85	0.38	0.83	0.86	0.76		0.3	-0.12	0.8	0.29	0.06	0.97
Non Currrent Assets Other	0.11	-0.4	-0.1	-0.26	0.22	0.63	0.18	-0.25	-0.25	-0.25	-0.57	-0.33	-0.39	-0.61	0.21	-0.35	0.16	0.0	-0.04	0.3		0.61	0.27	-0.33	-0.42	0.34
Common Stock Total Equity	-0.27	-0.17	-0.28	-0.11	-0.17	0.66	-0.18	-0.33	-0.33	-0.34	-0.45	-0.41	-0.54	-0.58	-0.2	-0.45	-0.24	-0.29	-0.35	-0.12	0.61		-0.15	-0.34	-0.3	-0.09
Non Current Liabilities Total	0.68	-0.53	0.46	-0.62	0.99	0.06	0.74	-0.17	-0.17	0.27	-0.39	0.12	-0.05	-0.26	0.98	0.12	0.98	0.65	0.76	0.8	0.27	-0.15		-0.01	-0.24	0.69
Property Plant And Equipment Gross	0.5	0.78	0.51	0.64	0.03	-0.42	0.49	0.02	0.02	0.92	0.82	0.93	0.6	0.69	0.15	0.89	0.11	0.56	0.28	0.29	-0.33	-0.34	-0.01		0.16	0.32
Short Term Debt	0.17	0.31	0.55	0.38	-0.11	-0.39	0.0	0.05	0.05	0.19	0.28	0.31	0.24	0.42	-0.12	0.26	-0.11	0.27	0.11	0.06	-0.42	-0.3	-0.24	0.16		0.09
Intangible Assets	0.89	-0.11	0.65	0.02	0.72	0.16	0.81	-0.14	-0.14	0.54	-0.08	0.38	-0.01	-0.1	0.75	0.37	0.73	0.85	0.62	0.97	0.34	-0.09	0.69	0.32	0.09

Click cells to compare fundamentals

Xtant Medical Account Relationship Matchups

Xtant Medical balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	41.5M	54.7M	60.2M	92.6M	106.5M	60.0M
Other Current Liab	5.7M	3.9M	5.0M	10.4M	12.0M	12.6M
Total Current Liabilities	25.6M	11.1M	15.2M	23.0M	26.4M	16.0M
Total Stockholder Equity	14.5M	30.9M	34.2M	51.3M	59.1M	62.0M
Net Debt	16.2M	(1.4M)	(3.2M)	17.8M	20.5M	19.5M
Retained Earnings	(230.3M)	(235.2M)	(243.7M)	(243.0M)	(218.7M)	(207.8M)
Accounts Payable	2.3M	2.6M	3.5M	7.1M	8.1M	4.9M
Cash	2.3M	18.2M	20.3M	5.7M	6.6M	5.8M
Cash And Short Term Investments	2.3M	18.2M	20.3M	5.7M	6.6M	5.8M
Net Receivables	6.9M	7.2M	10.9M	20.7M	23.8M	25.0M
Common Stock Shares Outstanding	28.5M	85.5M	94.1M	126.8M	145.8M	153.1M
Liabilities And Stockholders Equity	41.5M	54.7M	60.2M	92.6M	106.5M	60.0M
Inventory	21.4M	17.9M	17.3M	36.9M	42.4M	44.5M
Other Current Assets	1.5M	988K	1.6M	1.5M	1.8M	1.9M
Other Stockholder Equity	244.9M	266.1M	277.8M	294.3M	338.5M	355.4M
Total Liab	27.0M	23.8M	26.1M	41.3M	47.5M	60.8M
Total Current Assets	31.4M	44.3M	49.3M	64.9M	74.6M	78.3M
Short Long Term Debt Total	18.5M	16.8M	17.1M	23.6M	27.1M	50.1M
Property Plant And Equipment Net	6.0M	6.5M	7.2M	10.2M	11.7M	7.8M
Non Current Assets Total	10.1M	10.4M	10.9M	27.7M	31.9M	28.2M
Non Currrent Assets Other	402K	287K	197K	141K	126.9K	120.6K
Non Current Liabilities Total	1.3M	12.7M	10.8M	18.3M	21.0M	20.0M
Property Plant And Equipment Gross	4.3M	6.5M	7.2M	29.9M	34.4M	36.1M
Short Term Debt	17.7M	4.6M	6.8M	5.5M	6.3M	3.9M
Intangible Assets	457K	400K	344K	10.1M	11.6M	7.8M
Other Assets	2.1M	287K	197K	1.0	0.9	0.86
Property Plant Equipment	6.8M	4.3M	6.5M	5.8M	6.7M	7.6M
Retained Earnings Total Equity	(215.0M)	(223.3M)	(230.3M)	(243.7M)	(219.3M)	(208.3M)
Net Tangible Assets	(47.9M)	10.9M	27.3M	30.6M	35.2M	37.0M
Capital Surpluse	171.3M	179.1M	244.9M	277.8M	319.5M	177.0M
Capital Lease Obligations	1.7M	1.4M	1.7M	1.8M	2.0M	1.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Xtant Historical Balance Sheet

Xtant Medical Inventory

44.54 Million

About Xtant Balance Sheet Analysis

Xtant Medical Balance Sheet Chart

Total Assets

Total Current Liabilities

Accounts Payable

Xtant Medical balance sheet Correlations

Xtant Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Xtant Medical balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Xtant Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Short Long Term Debt Total	+ 0.99	Net Debt
Non Current Liabilities Total	+ 0.99	Net Debt
Short Long Term Debt Total	+ 0.99	Total Liab
Total Liab	+ 0.98	Net Debt
Non Current Liabilities Total	+ 0.98	Total Liab

Other Stockholder Equity	- 0.9	Retained Earnings
Other Current Assets	- 0.73	Retained Earnings
Common Stock Shares Outstanding	- 0.68	Retained Earnings
Total Current Assets	- 0.67	Retained Earnings
Non Current Liabilities Total	- 0.62	Total Stockholder Equity
Non Currrent Assets Other	- 0.61	Other Stockholder Equity